Copyright© 2021 - Bay Clinical R&D Services - All Rights Reserved

Due Diligence

Acquiring, in-lisencing therapeutic agents or entering into partnerships and collaborations requires biotech and pharma companies to perform very detailed due diligence of the new opportunity to provide the board and investors a true picture of the capabilities and likely pitfalls of the proposed venture. BCR&DS has participated in various due diligence efforts on behalf of companies and investment funds both in the acquisition of marketed and in development pharmaceuticals as well as groups of assets and mergers. A list of such previous experience can be provided upon request. A brief summary of our capabilities and extent of services in due diligence is included in this document. Download PDF